NASDAQ$BTTC

Black Titan Corp · Q3 2018 earnings

Q3 2018 earnings · Reported Nov 14, 2018 (8 years ago) · Investor relations

Nov 14Sep 30, 2018

Total Revenue

$562K

Previous: $40K+1304.3%

EPS (adj)

-$396.00

Previous: -$720.00+45.0%

Capital Expenditures

$0.00

Previous: $129K-100.0%

Free Cash Flow

-$60.3K

Previous: -$3.67M+98.4%

Net Income

-$54.1K

Previous: -$4.19M+98.7%

Operating Income

-$42.9K

Previous: -$4.07M+98.9%

Gross Profit

$352K

Previous: -$2.67M+113.1%

Cash & Equivalents

$47.6K

Previous: $11.7M-99.6%

Total Assets

$4.12M

Previous: $12.7M-67.7%

Stock-Based Comp

$388K

Previous: $404K-4.0%

Titan Pharmaceuticals · Revenue · Quarterly

$562K

Q3 2018+1,304.3%vs Q3 2017

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation